SAN FRANCISCO, CA—Stimulating the growth of new neurons to replace those lost in Alzheimer's disease (AD) is an intriguing therapeutic possibility. But will the factors that cause AD allow the new neurons to thrive and function normally?
Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Julie Langelier, Science Writer and Public Relations Specialist
Direct line: 415.734.5000
Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019
SAN FRANCISCO, CA—November 9, 2009—The Gladstone Institutes today announced that it has hired Bruce Spaulding, who recently retired as UCSF'S senior vice chancellor of advancement and planning as its new chief of strategic planning, effective December 14th.
SAN FRANCISCO, CA—November 1, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine t
SAN FRANCISCO, CA—October 28, 2009—For the fifth year in a row, The J. David Gladstone Institutes has placed among the top 10 among the Best Places to Work in Academia.
SAN FRANCISCO, CA—October 28, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) will receive $10 million over the next 6 years to find the genetic causes of congenital heart disease.
SAN FRANCISCO, CA—October 23, 2009—The J. David Gladstone Institutes today announced that Robert Sanders “Sandy” Williams, MD, has been appointed the new president of the Institutes. Dr.
SAN FRANCISCO, CA—October 13, 2009—The National Institutes of Health (NIH) has awarded a “Grand Opportunity” grant of $3.7 million to a consortium formed with the Gladstone Institute of Neurological Disease(GIND) and the Taube-Koret Center for Huntington's Disease Research to use stem cell techno
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the the Gladstone Institute of Cardiovascular Disease (GICD) and Kyoto University, has won the 2009 Albert Lasker Basic Medical Research Award for his discovery of a method of reprogramming adult skin cells to become embryonic-like stem cells.
SAN FRANCISCO, CA—September 2, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have traced the evolution of the four-chambered human heart to a common genetic factor linked to the development of hearts in turtles and other reptiles.
SAN FRANCISCO, CA—August 19, 2009—The J. David Gladstone Institutes announced a collaboration with Alitora Systems to develop software technology that facilitates organizational collaboration and enables rapid acceleration of the discovery and evaluation of new drugs.